Radiopharm Theranostics Files 6-K for July 2025
Ticker: RDPTF · Form: 6-K · Filed: Jul 29, 2025 · CIK: 1949257
| Field | Detail |
|---|---|
| Company | Radiopharm Theranostics Ltd (RDPTF) |
| Form Type | 6-K |
| Filed Date | Jul 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, sec-filing
TL;DR
Radiopharm Theranostics (RPTX) filed a 6-K for July 2025, confirming its foreign private issuer status and 20-F filing.
AI Summary
Radiopharm Theranostics Limited filed a Form 6-K on July 29, 2025, reporting information for the month of July 2025. The company is a foreign private issuer and is subject to the 1934 Act, with its principal executive office located in Carlton South, Victoria, Australia. The filing indicates the company will file annual reports under cover of Form 20-F.
Why It Matters
This filing provides routine updates for investors and regulators regarding Radiopharm Theranostics' status as a foreign private issuer and its reporting obligations.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- Radiopharm Theranostics Limited (company) — Registrant
- 001-41621 (company) — SEC File Number
- 20250729 (date) — Filing Date
- July 2025 (date) — Reporting Period
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer filed by Radiopharm Theranostics Limited for the month of July 2025, providing information to the U.S. Securities and Exchange Commission.
What is Radiopharm Theranostics Limited's SEC file number?
Radiopharm Theranostics Limited's SEC file number is 001-41621.
Where is Radiopharm Theranostics Limited's principal executive office located?
The company's principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
Does Radiopharm Theranostics Limited file annual reports under Form 20-F or 40-F?
The filing indicates that Radiopharm Theranostics Limited files annual reports under cover of Form 20-F.
Is Radiopharm Theranostics Limited furnishing information under Rule 12g3-2(b)?
No, the filing indicates 'No' for furnishing information under Rule 12g3-2(b) of the Securities Exchange Act of 1934.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 29, 2025 regarding Radiopharm Theranostics Ltd (RDPTF).